SCHEMBL3650504

SCHEMBL3650504

C[N]S(=O)(=O)OC

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL14612097 0.71
SCHEMBL2459269 0.69
SCHEMBL4666118 0.69
SCHEMBL16118424 0.67
SCHEMBL9410113 0.65
SCHEMBL10022031 0.65
SCHEMBL9410144 0.65
SCHEMBL4666505 0.65
SCHEMBL9410118 0.65
SCHEMBL12061364 0.63

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2203427-A2 5-ARYL-4,5-DIHYDRO-(1H)-PYRAZOLES AS CANNABINOID CB1 RECEPTOR AGONISTS Abbott Healthcare Products B.V. (NL) 2010-07-07 EP claimed
WO-2009037244-A2 5-ARYL-4,5-DIHYDRO-(1H)-PYRAZOLES AS CANNABINOID CB1 RECEPTOR AGONISTS SOLVAY PHARMACEUTICALS B.V. (NL) 2009-03-26 WO claimed
EP-0600147-A1 Tetralones with pharmacological activity, compositions containing them and process for their preparation J. URIACH &amp; CIA. S.A. (ES) 1994-06-08 EP disclosed